#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

Summary of #401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

by Peter Attia, MD

1h 4m•July 27, 2026
Listen to Episode

Overview of #401 – How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

Peter Attia argues that some of the most important advances in modern medicine did not begin as disease-focused projects. Instead, they came from scientists asking basic, open-ended questions about how nature works—why jellyfish glow, how fungi survive, what snake venom does, why bacteria have repeated DNA sequences, or how a desert lizard handles metabolism. Those curiosity-driven discoveries later became the foundation for major drug classes, laboratory tools, and therapies that have improved or saved millions of lives.

Core Thesis

The episode’s central idea is that basic science is a major engine of medical progress.

  • Many breakthrough therapies started as “irrelevant” or purely exploratory research.
  • Nature often already contains solutions to biological problems.
  • Scientists usually do not invent the underlying mechanism first; they discover it, understand it, and then translate it into medicine.
  • Because it is so hard to predict which curiosity-driven project will matter, Attia argues for protecting and valuing basic research even when its immediate clinical payoff is unclear.

Landmark Discoveries and What They Enabled

Green Fluorescent Protein (GFP) — Jellyfish to modern cell biology

  • Discovery: Osamu Shimomura studied the jellyfish Aequorea victoria to understand bioluminescence and isolated:
    • Aequorin (blue light, calcium-dependent)
    • GFP (green fluorescent protein)
  • Why it mattered: GFP can be inserted into almost any organism and still fluoresce.
  • Impact: It became one of biology’s most important tools for:
    • tracking proteins in living cells
    • observing cancer metastasis
    • studying embryonic development
    • monitoring neuron activity
    • building fluorescent biosensors like GCaMP
  • Recognition: Shimomura, Martin Chalfie, and Roger Tsien won the 2008 Nobel Prize in Chemistry.

Statins — Fungal warfare becomes cholesterol medicine

  • Discovery: Akira Endo reasoned that fungi might already contain molecules that block cholesterol synthesis.
  • He screened microbial strains and found inhibitory activity from fungal compounds.
  • Impact: This led to lovastatin and then the statin class:
    • simvastatin
    • pravastatin
    • atorvastatin
    • rosuvastatin
  • Clinical significance: Statins have prevented countless cardiovascular events and premature deaths.

ACE inhibitors — Snake venom leads to blood-pressure therapy

  • Discovery: Research on the venom of the Brazilian pit viper (Bothrops jararaca) revealed:
    • bradykinin
    • bradykinin potentiating factors (BPFs)
  • These findings helped identify ACE (angiotensin-converting enzyme) as a key target.
  • Impact: Medicinal chemists transformed venom peptides into captopril, the first oral ACE inhibitor.
  • Downstream drug classes:
    • captopril
    • enalapril
    • lisinopril
    • ramipril
    • and later ARBs such as losartan and valsartan
  • Clinical significance: These drugs are central to treating:
    • hypertension
    • heart failure
    • chronic kidney disease
    • post-MI remodeling
    • diabetic nephropathy

PCR and Taq polymerase — Hot springs unlock modern molecular biology

  • Discovery: Thomas Brock studied microbes in Yellowstone hot springs and isolated Thermus aquaticus.
  • Its heat-stable enzyme, Taq polymerase, became essential for PCR (polymerase chain reaction).
  • Impact: PCR made it possible to cheaply and rapidly amplify DNA.
  • Why it matters: PCR underpins:
    • genetic testing
    • forensic DNA analysis
    • cancer mutation testing
    • prenatal screening
    • ancestry testing
    • genomics
    • viral diagnostics
    • recombinant protein production
    • gene therapy development
  • Bottom line: PCR is one of the enabling technologies of modern medicine.

CRISPR — Bacterial immune memory becomes gene editing

  • Discovery: Francisco Mojica studied strange repeat sequences in the genome of salt-tolerant archaea from Spanish salt flats.
  • He realized the spacer sequences matched bacteriophage DNA, showing that CRISPR was a kind of adaptive immune system.
  • Impact: Jennifer Doudna, Emmanuelle Charpentier, and Feng Zhang helped turn this into programmable genome editing.
  • Clinical significance: CRISPR has already reached the clinic:
    • Casgevy became the first CRISPR-based therapy approved by the FDA in 2023 for sickle cell disease
  • The episode also notes early promise for CRISPR-based therapies in conditions like familial hypercholesterolemia.

GLP-1 drugs — A desert lizard inspires metabolic medicine

  • Discovery: John Eng studied venom from the Gila monster and identified exendin-4.
  • Exendin-4 resembled human GLP-1 but had a much longer half-life.
  • Impact: It became the basis for the first GLP-1 receptor agonist drug, exenatide (Byetta).
  • Downstream evolution: This line of discovery ultimately led to:
    • liraglutide
    • semaglutide
    • tirzepatide
  • Clinical significance: These drugs are transforming:
    • type 2 diabetes treatment
    • obesity care
    • cardiovascular risk reduction
    • and are being studied for heart failure, kidney disease, sleep apnea, addiction, and possibly Alzheimer’s disease

What These Stories Have in Common

A pattern of curiosity-first science

In each case, the original researcher was not primarily trying to cure a human disease:

  • studying jellyfish light
  • studying fungal metabolites
  • studying snake venom
  • studying heat-loving bacteria
  • studying DNA repeats in archaea
  • studying lizard venom and pancreatic biology

The medical breakthroughs came later, after others recognized the importance of the basic finding and translated it into practical use.

Nature as a pre-existing toolbox

Attia emphasizes that evolution has spent billions of years experimenting with:

  • signaling pathways
  • enzymes
  • immune systems
  • metabolic controls
  • stress adaptations
  • defense mechanisms

Human medicine often succeeds by finding those natural solutions and adapting them.

Main Takeaways

  • Basic research is not a luxury; it is a foundation of modern medicine.
  • The most transformative discoveries are often unpredictable and may appear useless at first.
  • Nature frequently “solves” biological problems before humans do.
  • Translational medicine depends on curiosity-driven science as much as it depends on intentional drug development.
  • Funding and policy should not be based only on immediate clinical relevance, because many of medicine’s biggest wins came from questions that did not look medically important at the time.

Attia’s Broader Argument on Science Funding

Attia is careful not to claim that all basic research is valuable by default. His point is more specific:

  • not every exploratory project will matter
  • rigorous peer review still matters
  • but near-term translational impact is a poor predictor of future significance

He argues that societies should be more willing to support scientists asking strange, open-ended questions, because those are often the questions that eventually reshape medicine.

Closing Message

The episode’s final message is one of humility: many of the drugs, diagnostics, and lab technologies we now take for granted began as tiny acts of curiosity about the natural world. Medicine advances not just through engineering and clinical intent, but through patient observation, basic discovery, and the willingness to explore places that do not obviously seem relevant to disease.